Definitive Contract HHSN268201400008C
Award Date
11/26/13
Potential Completion Date
5/31/17
Potential Value
$778K
Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Allegheny-West, PA 15212, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
31
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Humacyte Global Inc., a for-profit manufacturer, for the "Vascular Interventions/Innovations and Therapeutic Advances (VITA): Bioengineered Grafts for Peripheral Vascular Disease" program. The contract, which has a potential value of $1,570,756.00, is for a base period from November 15, 2013 to November 14, 2014, with a completion...
This is a $56,470 firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the U.S. Department of Health and Human Services, to Allegheny-Singer Research Institute (AHN Research Institute). The contract does not have a set-aside designation. Through this contract, AHN Research Institute, a non-profit hospital and research organization, is providing services related to the NICHD's research programs. Based...
This is a $608,546.79 definitive contract awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to the Medical College of Wisconsin, Inc. (MCW), a private medical school, to conduct the "Vascular Interventions/Innovations and Therapeutic Advances (VITA): A Study to Identify Molecules (Similar to RR505) that Targets Dual Specific Phosphatase5 (DUSP5)" program. The contract is a cost-no-fee arrangement with a...
This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
This is a federal contract award for a clinical trial worth $52,305,052.81, awarded by the National Heart Lung and Blood Institute (NHLBI) to the Medstar Health Research Institute, Inc. (doing business as Medstar Research Institute), a non-profit organization. The contract is a definitive, cost-no-fee agreement with a period of performance ending in June 2014. Medstar Research Institute has extensive experience collaborating with federal health agencies on a variety of research and clinical...
<p>This is a Cost Plus Fixed Fee contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Vascumab LLC (doing business as Staten Biotechnology) for the development of HDAC inhibitors for the treatment of pulmonary arterial hypertension. The contract has a ceiling value of $502,312.06 and a period of performance through August 31, 2018. The contract does not have a set-aside designation. Vascumab LLC is a minority-owned, small disadvantaged business.</p>
This firm-fixed price contract award to Medstar Research Institute Inc., a non-profit organization, was made by the National Heart, Lung and Blood Institute (NHLBI) and has a ceiling value of $363,039.00. The contract is for the provision of interventional cardiology services, including conducting cardiovascular magnetic resonance imaging (MRI) studies and supplying MRI consumables for NHLBI research. Medstar Research Institute has extensive experience collaborating with federal health...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $1,100,000.00 firm-fixed-price purchase order contract to Transmural Systems LLC, a woman-owned small business, for the manufacture of 200 Active Guidewires for MRI-guided cardiovascular catheterization. This contract is part of the National Heart, Lung, and Blood Institute's Division of Intramural Research's efforts to develop radiation-free heart catheterization...
This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the University of Pittsburgh, a non-profit educational institution, for the "Long Term Oxygen Treatment Trial". The definitive cost-no-fee contract has a ceiling value of $2,552,564.24 and a completion date of June 30, 2016. The contract does not have a set-aside designation. The University of Pittsburgh, a major recipient of federal research funding, is serving as the...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute awarded a Firm Fixed Price Purchase Order for Interventional Cardiology Support Services to Medstar Health Research Institute Inc., a non-profit organization. The contract, with a potential value of $537,999.98, was awarded on September 18, 2018 with a completion date of October 31, 2021. The contract was not set aside for any specific business type. Medstar Health...